Core Viewpoint - Smoore International (06969.HK) announced the grant of a total of 540,000 award shares to 10 eligible participants under the revised share award plan, pending acceptance by the participants [1] Group 1 - The company will issue the shares on October 15, 2025 [1] - The grant is subject to acceptance by the participants [1]

Group 1 - The company, Smoore International (06969), announced the grant of a total of 1.18 million stock options to 9 eligible participants on October 15, 2025 [1] - The exercise price for the stock options is set at HKD 15.72 per share [1]

Group 1 - The company Smoore International (06969) announced the grant of a total of 1.18 million stock options to 9 eligible participants on October 15, 2025 [1] - The exercise price for the stock options is set at HKD 15.72 per share [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損 失承擔任何責任。 Smoore International Holdings Limited 思 摩 爾 國 際 控 股 有 限 公 司 （ 於開曼群島註冊成立的有限公司） （股份代號：6969） 授出獎勵股份 本公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第17.06A， 17.06B及17.06C條作出。茲提述思摩爾國際控股有限公司（「本公司」）日期為2025年2月18日 之 公 告（「 該 公 告 」）， 內 容 有 關 本 公 司 股 東 批 准 經 修 訂 股 份 獎 勵 計 劃（「 經 修 訂 股 份 獎 勵 計 劃」）。除文義另有所指外，本公告所用詞彙與該公告所界定者具有相同涵義。 授出獎勵股份 董事會宣佈，於2025年10月15日，本公司根據經修訂股份獎勵計劃之條款，向10名合資格 參與者（「承授人」），授出合共540,000股獎勵股份（「授出事項」），惟授出事項須待承授人接 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損 失承擔任何責任。 思 摩 爾 國 際 控 股 有 限 公 司 （ 於開曼群島註冊成立的有限公司） （股份代號：6969） 授出購股權 本公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第17.06A、 17.06B及17.06C條作出。 思摩爾國際控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事（「董事」）會（「董 事會」）宣佈，於2025年10月15日（「授出日期」），根據本公司股東於2025年2月18日批准的經 修 訂首 次公 開發 售後 購股 權計 劃（「 經修 訂購 股權 計劃」）向 本集 團9 名 合資 格參 與者（「承 授 人」）授出合計1,180,000股購股權（「購股權」）。根據經修訂購股權計劃，每名承授人須於董 事會可能釐定並通知有關承授人的期間內（ 不超過自授出日期起計30天（ 包括當日 ））支付1 港元，作為接納授出購股權的代價。 所授出購股權的詳情如下： – ...

Core Viewpoint - The report from CICC indicates a downward adjustment of 20% in the forecast for Smoore International's (06969) 2025 net profit attributable to shareholders, bringing it to 1.05 billion yuan, while the 2026 net profit forecast is raised by 11% to 1.88 billion yuan, reflecting a positive outlook driven by HNB product sales [1] Group 1: Financial Performance - For the first three quarters of 2025, the company reported revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, while net profit attributable to shareholders was 810 million yuan, a decrease of 23.8%. Adjusted net profit after accounting for stock incentive expenses was 1.18 billion yuan, showing a slight increase of 0.1% [2] - Quarterly net profit figures for 2025 were 200 million yuan in Q1, 300 million yuan in Q2, and 317 million yuan in Q3, with year-on-year changes of -43.4%, +12.7%, and -16.4% respectively, aligning with CICC's expectations [2] Group 2: Market Expansion and Product Development - The Glo Hilo brand is expanding steadily in Japan and Poland, with the company positioned as a leader in flavor restoration, heating speed, and brand image. The positive sales momentum of heating devices is expected to contribute to revenue [3] - The company anticipates continued growth in the European vaping market, driven by differentiated compliant products from small brands, while orders in the U.S. are expected to remain stable despite regulatory tightening [3] - The company is leading in global market share for open-system proprietary brands, with expectations of continued year-on-year growth in Q3 2025 [3] Group 3: Profitability and R&D Investment - Short-term profitability may be slightly pressured due to increased orders from small customers in the European vaping market and initial sales of HNB heating devices. However, profitability is expected to improve as orders for vaping products increase and high-margin HNB products gain traction [4] - The company is increasing R&D investments in vaping medical and HNB new businesses, which, combined with the impact of stock incentive expenses, resulted in a year-on-year net profit decline of 16.4% and an adjusted net profit increase of 4% in Q3 2025 [4] Group 4: Long-term Growth Prospects - The company expects Glo Hilo to accelerate its global expansion in 2026, with concentrated shipments of HNB products likely to drive revenue growth. New products, technologies, and customers are anticipated to open up long-term opportunities [5] - In the vaping medical sector, the acceleration of complex generic drug development and the gradual realization of innovative drug collaborations are expected to lead to commercialization, providing long-term growth potential [5]

Core Viewpoint - The report from CICC indicates a downward adjustment in the net profit forecast for Smoore International (06969) for 2025 by 20% to 1.05 billion yuan, while the 2026 net profit forecast is raised by 11% to 1.88 billion yuan, reflecting a strong performance driven by HNB product sales [1] Group 1: Financial Performance - For the first three quarters of 2025, the company reported revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, while the net profit attributable to shareholders was 810 million yuan, a year-on-year decrease of 23.8% [2] - Adjusted for stock incentive expenses, the net profit attributable to shareholders was 1.18 billion yuan, showing a slight year-on-year increase of 0.1% [2] - Quarterly net profit for 1Q, 2Q, and 3Q of 2025 was 200 million, 300 million, and 317 million yuan respectively, with year-on-year changes of -43.4%, +12.7%, and -16.4% [2] Group 2: Market Expansion and Product Performance - The Glo Hilo brand is expanding steadily in Japan and Poland, with the company positioned as a leader in flavor restoration, heating speed, and brand image [3] - The company anticipates continued growth in the European vaping market, driven by differentiated compliant products amid regulatory changes [3] - The open-system self-owned brand is leading in global market share, with expectations of continued year-on-year growth in 3Q25 [3] Group 3: Cost Structure and R&D Investment - Short-term profitability is impacted by the allocation of stock incentive expenses, while R&D investments remain high [4] - The company expects slight pressure on gross margins in the short term due to increased orders from small clients in the European vaping market and initial sales of HNB heating devices [4] - The net profit and adjusted net profit for 3Q25 showed year-on-year changes of -16.4% and +4% respectively [4] Group 4: Long-term Growth Prospects - The company is optimistic about the global expansion of HNB products, which is expected to drive performance in the coming years [5] - The combination of drug-device complex generic drug development and innovative drug collaborations is anticipated to lead to commercialization in the vaping medical sector, opening up long-term growth opportunities [5]

Core Viewpoint - Smoore International (06969) reported significant revenue growth in Q3 2025, reaching 4.197 billion yuan, a 27.2% year-on-year increase, but faced declining profitability with a net profit of 317 million yuan, down 16.4% year-on-year [1][10] Revenue Performance - The company achieved a record high quarterly revenue, with total revenue for the first three quarters of 2025 at 10.21 billion yuan, up 21.8% year-on-year [1] - Revenue growth was primarily driven by the enterprise client business and proprietary brand business, with overseas markets, particularly Europe and the US, contributing over 97% of revenue [1][4] Business Segments - Smoore International operates two main business segments: enterprise client business and proprietary brand business, both focusing on overseas markets, especially Europe [4] - The enterprise client business generated 2.734 billion yuan in Europe and other countries in the first half of 2025, a 38% increase, accounting for 57.7% of this segment's revenue [4] - The proprietary brand business saw revenue of 1.07 billion yuan in Europe and other countries, a 15.1% increase, contributing 84% of its segment revenue [4][5] Market Strategy - The company shifted its market strategy post-2022, focusing on overseas expansion after facing declines due to pandemic-related supply chain issues and domestic regulatory challenges [2] - The US and China markets showed weaker performance, with a 6.7% decline in the US proprietary brand revenue and only 0.5% revenue contribution from China [5] Research and Development - Smoore International invested heavily in R&D, with total R&D expenditure of 722 million yuan in the first half of 2025, focusing on electronic nicotine delivery systems [6][8] - The company holds a significant number of patents, with 839 new applications globally, ensuring a competitive edge in the electronic vaporization market [8] Profitability Challenges - The company's profitability is under pressure, with net profit margins declining from 20.67% in 2022 to 7.92% in the first three quarters of 2025 [9] - Increased R&D and operational costs have led to a rise in expense ratios, impacting overall profitability despite revenue growth [9] Market Outlook - Analysts have mixed views on Smoore International's future, with some predicting revenue growth driven by electronic cigarette sales but cautioning about declining net profits due to rising costs [10] - The company's growth potential hinges on regulatory conditions in key markets, with expectations for profitability to improve as overseas markets and new product lines continue to develop [10]

Core Viewpoint - Smoore International (06969) reported significant revenue growth in Q3 2025, reaching 4.197 billion yuan, a 27.2% year-on-year increase, but faced declining profitability with a net profit of 317 million yuan, down 16.4% year-on-year [1][11] Revenue Performance - The company achieved a record high quarterly revenue, with total revenue for the first three quarters of 2025 at 10.21 billion yuan, up 21.8% year-on-year [1] - Revenue growth was primarily driven by the enterprise client business and proprietary brand business, with overseas markets, particularly Europe and the US, contributing over 97% of revenue [1][5] Profitability Challenges - Despite revenue growth, net profit has declined for four consecutive years, with a net profit margin dropping to 7.92% in the first three quarters of 2025 [1][10] - The gross margin has also decreased from 43.3% in 2022 to 37.3% in the first half of 2025, indicating pressure on profitability [10] Business Segments - The company operates two main business segments: enterprise client business and proprietary brand business, both focusing on overseas markets, especially Europe [5][6] - The enterprise client business generated 2.734 billion yuan in Europe and other countries in the first half of 2025, a 38% increase, accounting for 57.7% of this segment's revenue [5] - The proprietary brand business saw revenue of 1.07 billion yuan in Europe and other countries, a 15.1% increase, contributing 84% of its segment revenue [5] Research and Development - Smoore International has invested heavily in R&D, with total R&D expenditure of 722 million yuan in the first half of 2025, focusing on electronic nicotine delivery systems [7][9] - The company holds a significant number of patents, with 839 new patent applications globally, indicating a strong commitment to innovation [9] Market Outlook - The company has shifted its market strategy post-2022, focusing on overseas expansion to recover from previous declines in revenue [2][11] - Despite challenges in the US and China markets, the company anticipates continued high growth in Europe and other international markets [6][11] Investment Sentiment - Analysts have mixed views on Smoore International, with some predicting revenue growth driven by electronic cigarette sales but cautioning about rising costs and declining net profit [11] - Others remain optimistic about the company's potential for recovery and growth, particularly in the HNB product line [11]

Group 1 - The report highlights a slight adjustment in the A-share market post-National Day, with the ChiNext index dropping by 3.86% [2] - The central bank's net withdrawal of funds amounted to 426.3 billion yuan after the holiday, indicating a return to liquidity in the market [2] - The report anticipates a more proactive fiscal policy and moderately loose monetary policy in the fourth quarter to address potential geopolitical risks and economic targets [2] Group 2 - The convertible bond market is experiencing a TACO trading phenomenon again, with a significant decrease in the scale of convertible bonds held by insurance institutions [4][32] - The report suggests maintaining a neutral to low position in convertible bonds in the short term while focusing on low-priced bonds with favorable terms [4][32] - The domestic micro-enterprise performance recovery is gaining consensus, with a focus on sectors like AI, semiconductors, and military electronics for potential growth [4][32] Group 3 - The public REITs market in China has undergone several phases, with the current stage focusing on normalizing issuance and addressing structural differentiation [6][34] - The cash flow discounting method is the primary valuation method for public REITs, with differences in valuation based on the type of underlying assets [6][36] - The report emphasizes the importance of macroeconomic conditions, regulatory changes, and liquidity in influencing the performance of public REITs [6][36] Group 4 - The report on Wuling Motors indicates a steady revenue growth of 2.0% year-on-year, with a significant increase in net profit by 306.2% [19][37] - The company has improved its gross margin to 12.0%, reflecting enhanced product value and cost control [19][39] - Wuling Motors is strategically focusing on new energy and intelligent vehicle layouts, with its joint venture brand showing a 9% increase in sales [19][40]